Skip to Content
 
 
 
 

EA1181: CompassHER2-pCR: Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of the CompassHER2 Trials (Comprehensive use of Pathologic response Assessment to optimize therapy in HER2-postitive breast cancer (Location: Sioux Falls)

Objective

Clinical Trial Details >>

Principal Investigator(s)
Jason Jones, MD

Clinical Trial Categories

  • Breast Cancer
Contact
Gynecology Breast Coordinators at 605-322-7536
or gyn.breastresearch@avera.org

Location

  • Avera Cancer Institute at Sioux Falls
    1000 E. 23rd Street
    Sioux Falls, SD 57105
    Main: 605-322-3000
    Alternate: 800-657-4377

Moving Health Forward

Avera is a health ministry rooted in the Gospel. Our mission is to make a positive impact in the lives and health of persons and communities by providing quality services guided by Christian values.

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.